Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FOXO TechnologiesFOXOD +15.61% Cash Ratio is 0.00 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, FOXO Technologies ranks worse than 150150% on this metric.
FOXO Technologies has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for FOXO Technologies's Cash Ratio or its related term are showing as below:
During the past 6 years, FOXO Technologies's highest Cash Ratio was 13.23. The lowest was 0.01. And the median was 0.21.
FOXOD's Cash Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.58 * Ranked among companies with meaningful Cash Ratio only.
FOXO Technologies (OTCPK:FOXOD) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
FOXO Technologies Cash Ratio Related Terms
FOXO Technologies Cash Ratio Historical Data
* Premium members only.
The historical data trend for FOXO Technologies's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, FOXO Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FOXO Technologies Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's Cash Ratio distribution charts can be found below:
* The bar in red indicates where FOXO Technologies's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FOXO Technologies (FOXOD) has a Cash Ratio of 0.00 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on FOXO Technologies and its competitors. Over the past decade, FOXO Technologies' Cash Ratio has ranged from 0.01 to 13.23. According to the industry distribution chart, FOXO Technologies ranks #999999 out of 666 companies in the Healthcare Providers & Services industry.
Is FOXO Technologies' Cash Ratio too high?
FOXO Technologies' current Cash Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 13.23. Based on the distribution chart, FOXO Technologies ranks #999999 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does FOXO Technologies' Cash Ratio compare to NHLG and BACK?
According to the Healthcare Providers & Services industry distribution chart, FOXO Technologies ranks #999999 out of 666 companies for Cash Ratio. This places FOXO Technologies in the lower half of its industry. The industry median Cash Ratio is 0.58. Historically, FOXO Technologies' own Cash Ratio has ranged from 0.01 to 13.23 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on FOXO Technologies and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FOXO Technologies's current Cash Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
FOXO Technologies (FOXOD) has a current Cash Ratio of 0.00. The current Cash Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For FOXO Technologies (FOXOD), the current Cash Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOXOD has been successfully added to your 
